Hongzhou Lu
- Infectious Diseases top 0.2%
- Epidemiology top 2%
- Neurology top 1%
- Radiology, Nuclear Medicine and Imaging top 1%
- Molecular Biology top 10%
- Topics
- COVID-19 Clinical Research Studies (34 papers)SARS-CoV-2 and COVID-19 Research (33 papers)Influenza Virus Research Studies (18 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hongzhou Lu
173 papers receiving 6.3k citations
Hit Papers
Peers
Comparison fields: 5 of 184
- Infectious Diseases 3.5k
- Epidemiology 1.3k
- Neurology 1.1k
- Radiology, Nuclear Medicine and Imaging 984
- Molecular Biology 742
Countries citing papers authored by Hongzhou Lu
This map shows the geographic impact of Hongzhou Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongzhou Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongzhou Lu more than expected).
Fields of papers citing papers by Hongzhou Lu
This network shows the impact of papers produced by Hongzhou Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongzhou Lu. The network helps show where Hongzhou Lu may publish in the future.
Co-authorship network of co-authors of Hongzhou Lu
This figure shows the co-authorship network connecting the top 25 collaborators of Hongzhou Lu. A scholar is included among the top collaborators of Hongzhou Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongzhou Lu. Hongzhou Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 9 | |
| 7 | 3 | |
| 8 | 3 | |
| 9 | 6 | |
| 10 | 6 | |
| 11 | 4 | |
| 12 | 138 | |
| 13 | 11 | |
| 14 | 1 | |
| 15 | 25 | |
| 16 | 5 | |
| 17 | 1 | |
| 18 | 11 | |
| 19 | 169 | |
| 20 | [Clinicopathologic and immunohistochemical features of vulvar Paget diseases]. | 5 |
About Hongzhou Lu
Hongzhou Lu is a scholar working on Infectious Diseases, Virology and Epidemiology, having authored 187 papers that have together received 6.5k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (34 papers), SARS-CoV-2 and COVID-19 Research (33 papers) and Influenza Virus Research Studies (18 papers). The work is most often cited by research in Infectious Diseases (3.5k citations), Modeling and Simulation (611 citations) and Neurology (1.1k citations). Hongzhou Lu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yi‐Wei Tang, Charles W. Stratton, Yun Ling, Yuxin Shi, Fei Shan, Fengxiang Song, Nannan Shi, Jie Shen, Zhiyong Zhang and Yebin Jiang. Their work appears in journals such as New England Journal of Medicine, The Lancet and Physical Review Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.